SARS-CoV-2 rapidly infects millions of people worldwide since December 2019. There is still no effective treatment for the virus, resulting in the death of more than one million …
The coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread worldwide recently, leading to …
TTH Le, LH Tran, MT Nguyen, MQ Pham… - Journal of …, 2023 - Taylor & Francis
Abstract Janus kinase 1 (JAK1) is a tyrosine kinase that is involved in the initiation of responses to a number of different cytokine receptor families. The JAK1-dependent pathway …
Heat shock protein 90 (Hsp90) is one of the most potential targets in cancer therapy. We have demonstrated using a combination of molecular docking and fast pulling of ligand …
ST Ngo, KB Vu, MQ Pham… - Royal Society Open …, 2021 - royalsocietypublishing.org
The winged-helix domain of the methyl methanesulfonate and ultraviolet-sensitive 81 (w MUS81) is a potential cancer drug target. In this context, marine fungi compounds were …
Preventing the biological activity of SARS-CoV-2 main protease using natural compounds is of great interest. In this context, using a combination of AutoDock Vina and fast pulling of …
Cervical cancer (CC) is one of the most common cancers in women worldwide in which most cases are diagnosed with the Human Papilloma Virus (HPV). At the present time, there is …
HT Le, LH Tran, HTT Phung - Journal of Biomolecular Structure and …, 2024 - Taylor & Francis
The COVID-19 pandemic sparked an unprecedented race in biotechnology in a search for effective therapies and a preventive vaccine. The continued appearance of SARS-CoV-2 …
NT Mai, NT Lan, TY Vu, NT Tung… - Journal of Molecular …, 2022 - Springer
Abstract Janus kinase 2 (JAK2) inhibitors are potential anticancer drugs in the treatment of lymphoma, leukemia, thrombocytosis and particularly myeloproliferative diseases. However …